Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth

Abstract. Pancreatic juice is supersaturated in calcium carbonate. CaCO3 crystal growth is controlled by lithostathine, a secretory protein synthesized by pancreatic acinar cells, first described as a constituent of pancreatic stones. It was recently reported that, in the thin descending limb of the Henle's loop, urine was supersaturated in CaCO3 (Coe FL, Parks JH: Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990: 38, 625–631. This observation suggested the presence in kidney of a similar inhibitor. In this study, we show that a protein immunologically related to lithostathine is actually present in urine of healthy subjects and in renal stones. Immunocytochemistry of kidney sections localized the protein to cells of the proximal tubules and thick ascending limbs of the Henle's loops. Protein extracts of renal stones inhibited CaCO3crystal growth in vitro and this inhibition was significantly lifted by incubating the extracts with antibodies to lithostathine. The protein is not immunologically related to nephrocalcin. Because of its structural and functional similarities with pancreatic lithostathine, it was called renal lithostathine.

[1]  F. Coe,et al.  Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. , 1990, Kidney international.

[2]  J. Dagorn,et al.  Renaming pancreatic stone protein as 'lithostathine'. , 1990, Gastroenterology.

[3]  R. Rege,et al.  Isolation of an acidic protein from cholesterol gallstones, which inhibits the precipitation of calcium carbonate in vitro. , 1989, The Journal of clinical investigation.

[4]  F. Coe,et al.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. , 1989, The American journal of physiology.

[5]  J. Dagorn,et al.  Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis. , 1989, The Journal of clinical investigation.

[6]  H. Sarles,et al.  Complete amino acid sequence of an immunoreactive form of human pancreatic stone protein isolated from pancreatic juice. , 1987, European journal of biochemistry.

[7]  Y. Nakagawa,et al.  Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. , 1987, The Journal of clinical investigation.

[8]  R. Scott,et al.  Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff. , 1987, British journal of urology.

[9]  H. Sarles,et al.  Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein. , 1986, The Biochemical journal.

[10]  H. Sarles,et al.  Immunocytochemical Localization of Pancreatic Stone Protein in the Human Digestive Tract , 1986, Pancreas.

[11]  C. Figarella.  Pancreatic stone protein , 1985, Digestive diseases and sciences.

[12]  D. Lombardo,et al.  Pancreatic stone protein. II. Implication in stone formation during the course of chronic calcifying pancreatitis. , 1985, Gastroenterology.

[13]  D. Lombardo,et al.  The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth. , 1984, The Biochemical journal.

[14]  E. Kaiser,et al.  Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. , 1983, The Journal of biological chemistry.

[15]  D. Lombardo,et al.  Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic juice. , 1983, Biochemical and biophysical research communications.

[16]  F. Oppenheim,et al.  Phosphoproteins in the parotid saliva from the subhuman primate Macaca fascicularis. Isolation and characterization of a proline-rich phosphoglycoprotein and the complete covalent structure of a proline-rich phosphopeptide. , 1982, The Journal of biological chemistry.

[17]  W. N. Burnette,et al.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. , 1981, Analytical biochemistry.

[18]  H. Sarles,et al.  Characterization of a protein isolated from pancreatic calculi of men suffering from chronic calcifying pancreatitis. , 1979, Biochemical and biophysical research communications.

[19]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[20]  F. Carone,et al.  Contraluminal serum albumin uptake in isolated perfused renal tubules. , 1973, The American journal of physiology.

[21]  J. Schnermann,et al.  The effect of luminal application of colloids on rat proximal tubular net fluid flux. , 1972, Kidney international.

[22]  E. Bresler.  Aspects of tubular reabsorption revisited. , 1970, Chest.

[23]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[24]  H. Fleisch,et al.  Isolation from urine of pyrophosphate, a calcification inhibitor. , 1962, The American journal of physiology.

[25]  R. Ryall,et al.  The Effect of Macromolecules on the Crystallization of Calcium Oxalate in Human Urine , 1989 .

[26]  J. Sallis.  Glycosaminoglycans as inhibitors of stone formation. , 1987, Mineral and electrolyte metabolism.

[27]  Sallis Jd.  Glycosaminoglycans as inhibitors of stone formation. , 1987 .

[28]  B. Ulshöfer.  Epidemiological Aspects of Urolithiasis in a German County , 1985 .

[29]  W. Robertson,et al.  Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[30]  C. Tisher,et al.  Morphology of the ascending thick limb of Henle. , 1976, Kidney international.